The decision struck me as a rather pyrrhic victory for NXS. Ultimately, the takeovers panel decided not to make a declaration of unacceptable circumstances.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025